Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location Prognostic p-value RNA cancer category RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ABCB4 ABCB4, GBD1, MDR2, MDR3 , PFIC-3, PGY3 ENSG00000005471 ATP-binding cassette, sub-family B (MDR/TAP), member 4 7 87401697-87480435 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level HPA049395, HPA053288 Approved Approved Nucleoplasm
Plasma membrane
Actin filaments
Focal adhesion sites Tissue enriched Tissue enriched 6 liver: 69.2 adrenal gland: 10.7 ABCB6 EST45597, MTABC3, umat ENSG00000115657 ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group) 2 219209768-219218990 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level HPA046723, HPA058011 Approved Validated Nucleoplasm
Golgi apparatus
Plasma membrane
Mitochondria
Cytosol Renal cancer:1.52e-7 (unfavourable), Liver cancer:9.45e-7 (unfavourable) Expressed in all Expressed in all testis: 32.5 APBA2 D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L ENSG00000034053 Amyloid beta (A4) precursor protein-binding, family A, member 2 15 28884483-29118315 Predicted intracellular proteins Evidence at protein level CAB037065, HPA039400 Uncertain Approved Nucleoplasm
Golgi apparatus
Vesicles
Plasma membrane Tissue enhanced Tissue enhanced cerebral cortex: 12.2 spleen: 3.3 ARAP1 CENTD2 ENSG00000186635 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 11 72685069-72793599 Predicted intracellular proteins Evidence at protein level CAB020703, HPA070383 Approved Approved Nucleoplasm
Vesicles
Plasma membrane
Cytosol Pancreatic cancer:2.04e-5 (favourable), Thyroid cancer:6.41e-4 (favourable), Liver cancer:6.45e-4 (unfavourable) Expressed in all Expressed in all spleen: 92.9 ARHGAP29 PARG1 ENSG00000137962 Rho GTPase activating protein 29 1 94148988-94275068 Predicted intracellular proteins Evidence at protein level HPA026534 Approved Approved Nucleus
Plasma membrane
Centrosome
Cytosol Endometrial cancer:6.26e-5 (unfavourable), Pancreatic cancer:9.63e-4 (unfavourable) Expressed in all Mixed spleen: 50.5 ARHGAP40 C20orf95, dJ1100H13.4 ENSG00000124143 Rho GTPase activating protein 40 20 38601934-38651035 Predicted intracellular proteins Evidence at protein level HPA042636, HPA042840 Uncertain Supported Nucleoplasm
Plasma membrane
Centrosome
Cytosol Renal cancer:2.89e-4 (unfavourable) Mixed Group enriched 7 breast: 37.4;epididymis: 43.2;esophagus: 12.7;seminal vesicle: 11.2;skin: 53.9 stomach: 4.3 ARPC5 ARC16, dJ127C7.3, p16-Arc ENSG00000162704 Actin related protein 2/3 complex, subunit 5, 16kDa 1 183620846-183635757 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA022013, HPA031972 Approved Approved Vesicles
Plasma membrane
Cell Junctions
Cytosol Renal cancer:1.21e-10 (unfavourable), Liver cancer:3.63e-4 (unfavourable) Expressed in all Expressed in all appendix: 207.6 CDK5 PSSALRE ENSG00000164885 Cyclin-dependent kinase 5 7 151053812-151058530 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level CAB008909, HPA018977, HPA064535 Approved Supported Nucleus
Plasma membrane
Cell Junctions
Cytosol Expressed in all Expressed in all cerebral cortex: 50.0 CFLAR c-FLIP, CASH, CASP8AP1, Casper, CLARP, FLAME, FLIP, I-FLICE, MRIT ENSG00000003402 CASP8 and FADD-like apoptosis regulator 2 201116104-201176687 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level HPA019044, CAB022157, CAB025216 Uncertain Supported Nucleus
Nuclear bodies
Plasma membrane
Cytosol Head and neck cancer:2.79e-4 (favourable) Expressed in all Expressed in all bone marrow: 160.5 CRTC1 FLJ14027, KIAA0616, MECT1, TORC1 ENSG00000105662 CREB regulated transcription coactivator 1 19 18683677-18782333 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level HPA022035 Approved Supported Nucleoplasm
Nuclear bodies
Plasma membrane
Cytosol Pancreatic cancer:1.80e-5 (favourable), Renal cancer:3.83e-5 (favourable) Expressed in all Expressed in all cerebral cortex: 23.8 CRYL1 GDH, lambda-CRY, MGC149525, MGC149526 ENSG00000165475 Crystallin, lambda 1 13 20403667-20525857 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA040403 Supported Approved Nucleus
Nucleoli
Golgi apparatus
Plasma membrane Renal cancer:2.30e-9 (favourable), Endometrial cancer:1.76e-5 (favourable) Expressed in all Expressed in all kidney: 335.8 CTSV CTSL2, CTSU ENSG00000136943 Cathepsin V 9 97029679-97039643 Enzymes, Predicted secreted proteins Evidence at protein level CAB017112 Uncertain Approved Nucleus
Nucleoli fibrillar center
Plasma membrane
Cytosol Liver cancer:2.83e-5 (unfavourable), Urothelial cancer:2.39e-4 (unfavourable), Pancreatic cancer:2.87e-4 (unfavourable), Endometrial cancer:8.41e-4 (favourable) Mixed Tissue enhanced cervix, uterine: 68.9;skin: 64.3;testis: 131.2 placenta: 25.7 CTTN EMS1 ENSG00000085733 Cortactin 11 70398404-70436584 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB011235, HPA057242 Supported Supported Golgi apparatus
Vesicles
Plasma membrane
Cytosol Head and neck cancer:2.19e-6 (unfavourable), Liver cancer:4.45e-4 (unfavourable) Expressed in all Expressed in all gallbladder: 109.3 DOCK4 FLJ34238, KIAA0716 ENSG00000128512 Dedicator of cytokinesis 4 7 111726110-112206411 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA071516 Supported Nucleoli
Golgi apparatus
Plasma membrane
Cytosol Expressed in all Tissue enhanced cerebral cortex: 31.8 lung: 27.6 EFCAB7 KIAA1799, RP4-534K7.1 ENSG00000203965 EF-hand calcium binding domain 7 1 63523372-63572693 Predicted intracellular proteins Evidence at protein level HPA029611, HPA029612, HPA029613 Supported Approved Nucleus
Nucleoli
Plasma membrane
Cytosol Glioma:4.84e-4 (favourable) Mixed Mixed testis: 24.5 FAM222A C12orf34, FLJ14721 ENSG00000139438 Family with sequence similarity 222, member A 12 109714228-109770507 Predicted intracellular proteins Evidence at protein level HPA040181 Uncertain Approved Nucleoplasm
Plasma membrane
Focal adhesion sites
Mitochondria Cervical cancer:1.82e-5 (favourable), Pancreatic cancer:4.81e-4 (favourable), Stomach cancer:8.59e-4 (favourable) Expressed in all Tissue enhanced cerebral cortex: 20.1;testis: 16.6 adrenal gland: 9.9 FBXO16 FBX16 ENSG00000214050 F-box protein 16 8 28348287-28490318 Predicted intracellular proteins Evidence at transcript level HPA053955, HPA058676 Uncertain Approved Nucleoplasm
Vesicles
Plasma membrane
Cytosol Ovarian cancer:6.70e-5 (favourable) Mixed Tissue enhanced epididymis: 26.9 thyroid gland: 12.6 FBXO38 Fbx38, FLJ13962, MOKA, SP329 ENSG00000145868 F-box protein 38 5 148383935-148442836 Disease related genes, Predicted intracellular proteins Evidence at protein level HPA034821, HPA041444 Approved Supported Nucleoplasm
Plasma membrane
Cytokinetic bridge
Cytosol Expressed in all Expressed in all parathyroid gland: 30.2 FCHSD2 KIAA0769, SH3MD3 ENSG00000137478 FCH and double SH3 domains 2 11 72836745-73142261 Predicted intracellular proteins Evidence at protein level HPA038545, HPA038546 Uncertain Approved Nuclear speckles
Plasma membrane
Actin filaments
Focal adhesion sites Colorectal cancer:1.71e-4 (favourable) Expressed in all Expressed in all spleen: 65.0 FEN1 FEN-1, MF1, RAD2 ENSG00000168496 Flap structure-specific endonuclease 1 11 61792637-61797244 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB002262, HPA006581, HPA006748 Supported Approved Nucleus
Nucleoli
Plasma membrane
Mitochondria Liver cancer:3.39e-6 (unfavourable), Renal cancer:5.73e-6 (unfavourable), Ovarian cancer:7.85e-4 (favourable), Stomach cancer:9.46e-4 (favourable) Expressed in all Mixed lymph node: 35.2 FIGN ENSG00000182263 Fidgetin 2 163593396-163736012 Predicted intracellular proteins Evidence at protein level HPA034987, HPA057919 Approved Approved Nucleoplasm
Vesicles
Plasma membrane
Cell Junctions
Cytosol Mixed Mixed ovary: 5.1 FLNB ABP-278, FH1, FLN1L, LRS1, TABP, TAP ENSG00000136068 Filamin B, beta 3 58008400-58172251 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA004747, HPA004886, CAB019322 Supported Supported Golgi apparatus
Plasma membrane
Actin filaments
Cytosol Renal cancer:3.45e-6 (favourable), Pancreatic cancer:8.45e-5 (unfavourable) Expressed in all Expressed in all prostate: 161.4 FMNL3 DKFZp762B245, MGC45819, WBP3 ENSG00000161791 Formin-like 3 12 49636499-49708165 Predicted intracellular proteins Evidence at protein level HPA002552, HPA023201 Uncertain Supported Golgi apparatus
Vesicles
Plasma membrane
Cytosol Renal cancer:3.58e-5 (unfavourable) Expressed in all Mixed lymph node: 28.4 GAS2 ENSG00000148935 Growth arrest-specific 2 11 22625642-22813055 Predicted intracellular proteins Evidence at protein level HPA058904 Supported Approved Nucleus
Nucleoli
Plasma membrane
Cytosol Renal cancer:6.13e-4 (favourable) Tissue enhanced Tissue enhanced liver: 20.3 kidney: 5.8 GPR27 SREB1 ENSG00000170837 G protein-coupled receptor 27 3 71754050-71756496 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level HPA029395 Approved Approved Nucleoplasm
Plasma membrane
Actin filaments
Cytosol Ovarian cancer:1.21e-6 (favourable), Breast cancer:5.63e-4 (favourable) Mixed Tissue enhanced parathyroid gland: 45.7 cerebral cortex: 24.9 HAUS7 UCHL5IP, UIP1 ENSG00000213397 HAUS augmin-like complex, subunit 7 X 153447666-153495516 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA003614 Approved Nucleoli
Plasma membrane
Centrosome
Cytosol Renal cancer:3.94e-4 (unfavourable), Cervical cancer:6.12e-4 (favourable) Expressed in all Mixed skin: 64.0 INTS12 INT12, PHF22, SBBI22 ENSG00000138785 Integrator complex subunit 12 4 105682627-105895986 Cancer-related genes, Predicted intracellular proteins Evidence at protein level HPA035772, HPA041814 Approved Approved Nucleoplasm
Nuclear bodies
Plasma membrane
Cytosol Liver cancer:2.67e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 33.5 KIAA0895 ENSG00000164542 KIAA0895 7 36324221-36390125 Predicted intracellular proteins Evidence at transcript level HPA020512, HPA021036, HPA061066 Uncertain Approved Nucleus
Plasma membrane
Cell Junctions
Cytosol Expressed in all Tissue enhanced testis: 43.8 parathyroid gland: 23.4 LIMA1 EPLIN ENSG00000050405 LIM domain and actin binding 1 12 50175788-50283546 Predicted intracellular proteins Evidence at protein level HPA023871, HPA052645 Supported Validated Plasma membrane
Actin filaments
Focal adhesion sites
Cytosol Head and neck cancer:1.76e-6 (unfavourable), Renal cancer:2.79e-4 (favourable) Expressed in all Expressed in all rectum: 146.2 LMCD1 ENSG00000071282 LIM and cysteine-rich domains 1 3 8501707-8574673 Predicted intracellular proteins Evidence at protein level HPA024059 Approved Supported Nucleus
Plasma membrane
Cell Junctions
Cytosol Renal cancer:8.66e-5 (unfavourable) Expressed in all Mixed skeletal muscle: 201.9 LMTK2 AATYK2, BREK, cprk, KIAA1079, KPI-2, KPI2, LMR2, PPP1R100 ENSG00000164715 Lemur tyrosine kinase 2 7 98106885-98209633 Enzymes, Predicted membrane proteins Evidence at protein level HPA010657, HPA041836 Uncertain Approved Nuclear speckles
Plasma membrane
Microtubule organizing center
Cytosol Renal cancer:1.12e-7 (favourable), Ovarian cancer:8.03e-4 (unfavourable) Expressed in all Expressed in all cerebral cortex: 28.0 LRRC45 MGC20806 ENSG00000169683 Leucine rich repeat containing 45 17 82023302-82031151 Predicted intracellular proteins Evidence at protein level HPA023372, HPA023382, HPA024768 Supported Supported Nucleoplasm
Plasma membrane
Centrosome
Cytosol Renal cancer:1.54e-4 (unfavourable) Expressed in all Mixed fallopian tube: 8.2 MAP3K6 ASK2, MAPKKK6, MEKK6 ENSG00000142733 Mitogen-activated protein kinase kinase kinase 6 1 27355184-27366892 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA051192 Approved Approved Nucleus
Plasma membrane
Actin filaments
Cytosol Glioma:1.73e-4 (unfavourable), Head and neck cancer:7.26e-4 (favourable), Liver cancer:8.76e-4 (unfavourable) Expressed in all Tissue enhanced skin: 114.6 esophagus: 41.3 NCKAP5 ERIH1, ERIH2, NAP5 ENSG00000176771 NCK-associated protein 5 2 132671799-133568463 Predicted intracellular proteins Evidence at protein level HPA034639, HPA044859 Uncertain Approved Nucleoli
Golgi apparatus
Plasma membrane
Cytosol Mixed Tissue enhanced lung: 14.2 cerebral cortex: 4.1 PACSIN2 SDPII ENSG00000100266 Protein kinase C and casein kinase substrate in neurons 2 22 42835412-43015145 Predicted intracellular proteins Evidence at protein level HPA049854, HPA056520 Supported Supported Nuclear speckles
Vesicles
Plasma membrane
Cytosol Renal cancer:1.09e-13 (favourable), Liver cancer:7.33e-4 (unfavourable) Expressed in all Expressed in all adrenal gland: 95.8 PLEKHA4 PEPP1 ENSG00000105559 Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 19 48837097-48868632 Predicted intracellular proteins Evidence at protein level HPA042978, HPA048473 Uncertain Approved Plasma membrane
Cytokinetic bridge
Centrosome
Cytosol Breast cancer:1.97e-4 (favourable), Liver cancer:8.68e-4 (unfavourable) Expressed in all Mixed ovary: 22.5 PLEKHG3 ARHGEF43, KIAA0599 ENSG00000126822 Pleckstrin homology domain containing, family G (with RhoGef domain) member 3 14 64704102-64750247 Predicted intracellular proteins Evidence at protein level HPA063455, HPA065323 Supported Nucleoplasm
Plasma membrane
Cytokinetic bridge
Centrosome
Cytosol Renal cancer:7.39e-8 (favourable) Expressed in all Expressed in all seminal vesicle: 52.5 PLIN4 KIAA1881, S3-12 ENSG00000167676 Perilipin 4 19 4502180-4518465 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA044682, HPA054657 Supported Supported Vesicles
Lipid droplets
Plasma membrane
Cytosol Endometrial cancer:2.31e-4 (unfavourable), Colorectal cancer:8.31e-4 (unfavourable) Mixed Tissue enriched 14 adipose tissue: 810.9 skeletal muscle: 59.1 PPP2R1B PP2A-Abeta, PR65B ENSG00000137713 Protein phosphatase 2, regulatory subunit A, beta 11 111726908-111766427 Predicted intracellular proteins Evidence at protein level CAB004034, HPA018908 Approved Approved Nucleus
Plasma membrane
Centrosome
Cytosol Liver cancer:3.80e-4 (favourable) Expressed in all Expressed in all testis: 98.2 PTK6 BRK ENSG00000101213 Protein tyrosine kinase 6 20 63528001-63537370 Enzymes, Predicted intracellular proteins Evidence at protein level CAB032952, HPA036070, HPA036071 Approved Supported Nucleoplasm
Nuclear bodies
Plasma membrane
Cytosol Renal cancer:1.26e-9 (unfavourable), Pancreatic cancer:1.96e-4 (unfavourable) Mixed Tissue enhanced esophagus: 61.2;skin: 60.6 duodenum: 30.0 RIOK3 SUDD ENSG00000101782 RIO kinase 3 18 23452823-23486603 Enzymes, Predicted intracellular proteins Evidence at protein level HPA001620, HPA024184 Approved Approved Golgi apparatus
Plasma membrane
Microtubule organizing center
Cytosol Pancreatic cancer:4.10e-4 (unfavourable), Prostate cancer:5.80e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 75.0 S100A13 ENSG00000189171 S100 calcium binding protein A13 1 153618787-153631360 Predicted intracellular proteins Evidence at protein level HPA019592, CAB025494 Approved Approved Nucleus
Nucleoli
Plasma membrane
Cytosol Renal cancer:1.97e-4 (unfavourable) Expressed in all Expressed in all thyroid gland: 330.1 S100A2 CAN19, S100L ENSG00000196754 S100 calcium binding protein A2 1 153561108-153567890 Cancer-related genes, Predicted intracellular proteins Evidence at protein level CAB002600, CAB047340, HPA062451 Supported Supported Nucleus
Nucleoli
Plasma membrane
Cytosol Pancreatic cancer:2.04e-4 (unfavourable) Expressed in all Tissue enhanced esophagus: 1487.6;tonsil: 385.6 urinary bladder: 368.6 SC5D SC5DL ENSG00000109929 Sterol-C5-desaturase 11 121292453-121308694 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level HPA066283, HPA070248 Approved Approved Nucleoplasm
Endoplasmic reticulum
Plasma membrane
Cytosol Renal cancer:1.07e-7 (favourable), Head and neck cancer:3.30e-4 (unfavourable), Melanoma:3.98e-4 (unfavourable) Expressed in all Expressed in all liver: 193.1 SCAMP4 FLJ33847 ENSG00000227500 Secretory carrier membrane protein 4 19 1905214-1926013 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA043284 Approved Approved Golgi apparatus
Vesicles
Lipid droplets
Plasma membrane Endometrial cancer:4.40e-6 (favourable), Liver cancer:1.92e-5 (unfavourable), Renal cancer:3.56e-4 (favourable) Expressed in all Expressed in all fallopian tube: 58.6 SCRIB KIAA0147, SCRB1, Vartul ENSG00000180900 Scribbled planar cell polarity protein 8 143790920-143815379 Disease related genes, Predicted intracellular proteins Evidence at protein level CAB015463, CAB022081, HPA023557, HPA064312 Supported Validated Nucleoplasm
Plasma membrane
Cell Junctions
Rods & Rings Expressed in all Expressed in all skin: 22.0 SDE2 C1orf55, FLJ35382 ENSG00000143751 SDE2 telomere maintenance homolog (S. pombe) 1 225982702-225999331 Predicted intracellular proteins Evidence at protein level HPA028467, HPA031255, HPA031256 Approved Approved Nuclear speckles
Golgi apparatus
Plasma membrane
Cytosol Expressed in all Expressed in all thyroid gland: 21.0 SGCE DYT11 ENSG00000127990 Sarcoglycan, epsilon 7 94585230-94656209 Disease related genes, Predicted membrane proteins Evidence at protein level HPA074790 Approved Nucleoplasm
Golgi apparatus
Vesicles
Plasma membrane Head and neck cancer:1.61e-5 (unfavourable), Stomach cancer:1.35e-4 (unfavourable) Expressed in all Mixed ovary: 132.8 SIPA1 SPA1 ENSG00000213445 Signal-induced proliferation-associated 1 11 65585395-65650930 Predicted intracellular proteins Evidence at protein level CAB020833, HPA039867 Supported Approved Nucleus
Nucleoli
Golgi apparatus
Plasma membrane Renal cancer:3.52e-6 (unfavourable), Colorectal cancer:9.42e-4 (unfavourable) Expressed in all Tissue enhanced spleen: 101.8 lymph node: 72.4 SNRK FLJ20224, HSNFRK, KIAA0096 ENSG00000163788 SNF related kinase 3 43286512-43424764 Enzymes, Predicted intracellular proteins Evidence at protein level HPA042163 Uncertain Approved Nucleus
Vesicles
Plasma membrane
Cell Junctions Renal cancer:9.41e-5 (favourable), Breast cancer:9.28e-4 (favourable) Expressed in all Expressed in all placenta: 47.5 SSH3 FLJ10928, FLJ20515 ENSG00000172830 Slingshot protein phosphatase 3 11 67303448-67312607 Enzymes, Predicted intracellular proteins Evidence at protein level HPA019949, HPA019957 Approved Approved Nuclear speckles
Plasma membrane
Actin filaments
Cytosol Pancreatic cancer:2.89e-4 (unfavourable) Expressed in all Expressed in all seminal vesicle: 37.1 TES DKFZP586B2022, TESS-2, TESTIN ENSG00000135269 Testin LIM domain protein 7 116210493-116258783 Predicted intracellular proteins Evidence at protein level HPA015269, HPA018123 Approved Supported Plasma membrane
Cell Junctions
Focal adhesion sites
Cytosol Pancreatic cancer:1.20e-5 (unfavourable), Renal cancer:8.71e-5 (favourable) Expressed in all Expressed in all seminal vesicle: 269.2 TEX14 CT113 ENSG00000121101 Testis expressed 14 17 58556678-58692055 Enzymes, Predicted intracellular proteins Evidence at protein level HPA030620 Approved Vesicles
Plasma membrane
Cell Junctions
Cytosol Mixed Tissue enriched 43 testis: 49.0 bone marrow: 1.1 TLN1 ILWEQ, TLN ENSG00000137076 Talin 1 9 35696948-35732395 Plasma proteins, Predicted intracellular proteins Evidence at protein level CAB002006, HPA004748 Supported Supported Plasma membrane
Focal adhesion sites
Microtubule organizing center
Cytosol Colorectal cancer:5.56e-4 (unfavourable), Renal cancer:7.21e-4 (favourable) Expressed in all Expressed in all smooth muscle: 202.0 TRMT13 CCDC76, FLJ10287, FLJ11219 ENSG00000122435 TRNA methyltransferase 13 homolog (S. cerevisiae) 1 100133150-100150497 Enzymes, Predicted intracellular proteins Evidence at protein level HPA028494 Approved Approved Nucleoplasm
Nuclear bodies
Plasma membrane
Cytosol Renal cancer:6.89e-6 (unfavourable), Liver cancer:5.81e-5 (unfavourable) Expressed in all Expressed in all parathyroid gland: 28.8 UBA3 hUba3, NAE2, UBE1C ENSG00000144744 Ubiquitin-like modifier activating enzyme 3 3 69054730-69080408 Predicted intracellular proteins Evidence at protein level HPA034873, HPA034874, HPA065335 Supported Approved Nucleoplasm
Plasma membrane
Centrosome
Cytosol Liver cancer:8.57e-4 (unfavourable) Expressed in all Expressed in all bone marrow: 68.1 UBA52 CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40 ENSG00000221983 Ubiquitin A-52 residue ribosomal protein fusion product 1 19 18571730-18577550 Predicted intracellular proteins, Ribosomal proteins Evidence at protein level HPA041344, HPA049132, HPA056624 Supported Approved Nucleoplasm
Endoplasmic reticulum
Plasma membrane
Cytosol Expressed in all Expressed in all ovary: 1909.1 UBE2A HHR6A, RAD6A, UBC2 ENSG00000077721 Ubiquitin-conjugating enzyme E2A X 119574467-119591083 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level HPA003875, HPA051765, HPA065898 Supported Nucleoplasm
Vesicles
Plasma membrane
Cytosol Renal cancer:2.20e-6 (unfavourable), Cervical cancer:2.16e-4 (favourable), Head and neck cancer:9.07e-4 (unfavourable) Expressed in all Expressed in all placenta: 75.9 UBE2B HHR6B, RAD6B, UBC2 ENSG00000119048 Ubiquitin-conjugating enzyme E2B 5 134371179-134391992 Enzymes, Predicted intracellular proteins Evidence at protein level HPA003875, HPA051765, HPA065898 Supported Nucleoplasm
Vesicles
Plasma membrane
Cytosol Expressed in all Expressed in all adrenal gland: 99.5 VPS36 C13orf9, CGI-145, Eap45 ENSG00000136100 Vacuolar protein sorting 36 homolog (S. cerevisiae) 13 52412602-52450628 Predicted intracellular proteins Evidence at protein level HPA039734, HPA043947 Approved Supported Vesicles
Lysosomes
Plasma membrane
Cell Junctions Renal cancer:9.91e-6 (favourable) Expressed in all Expressed in all skin: 62.6 XPO6 FLJ22519, KIAA0370, RANBP20 ENSG00000169180 Exportin 6 16 28097979-28211920 Predicted intracellular proteins Evidence at protein level HPA038246 Uncertain Approved Nucleus
Nucleoli
Plasma membrane
Cytosol Liver cancer:3.68e-4 (unfavourable), Urothelial cancer:8.80e-4 (unfavourable) Expressed in all Expressed in all testis: 94.0 XRCC6BP1 KUB3 ENSG00000166896 XRCC6 binding protein 1 12 57941541-57957269 Enzymes, Predicted intracellular proteins Evidence at protein level HPA035804, HPA043204 Uncertain Validated Vesicles
Plasma membrane
Cell Junctions
Cytosol Renal cancer:1.44e-5 (unfavourable) Expressed in all Tissue enhanced testis: 26.6 rectum: 5.6 ZDHHC5 KIAA1748, ZNF375 ENSG00000156599 Zinc finger, DHHC-type containing 5 11 57667747-57701187 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level HPA014670 Approved Approved Nucleoplasm
Plasma membrane
Cell Junctions
Cytosol Pancreatic cancer:6.74e-5 (unfavourable) Expressed in all Expressed in all parathyroid gland: 86.1 ZNF18 HDSG1, KOX11, Zfp535, ZKSCAN6, ZNF535, ZSCAN38 ENSG00000154957 Zinc finger protein 18 17 11977439-11997510 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA006144 Uncertain Approved Nucleoplasm
Golgi apparatus
Plasma membrane
Cytosol Renal cancer:3.06e-6 (unfavourable), Pancreatic cancer:5.12e-6 (favourable), Cervical cancer:6.32e-4 (favourable) Expressed in all Expressed in all testis: 22.2 ZNF185 ENSG00000147394 Zinc finger protein 185 (LIM domain) X 152914442-152973480 Plasma proteins, Predicted intracellular proteins Evidence at protein level HPA000400, HPA016438 Supported Supported Plasma membrane
Actin filaments
Focal adhesion sites
Cytosol Pancreatic cancer:3.30e-5 (unfavourable), Lung cancer:1.50e-4 (unfavourable) Expressed in all Tissue enhanced epididymis: 393.3;esophagus: 279.4;seminal vesicle: 200.0 cervix, uterine: 104.7 ZNF276 CENP-Z, CENPZ, MGC45417, ZADT, ZFP276, ZNF477 ENSG00000158805 Zinc finger protein 276 16 89720400-89740903 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA021309, HPA022255 Uncertain Approved Nucleus
Nucleoli
Plasma membrane
Cytosol Renal cancer:3.37e-4 (unfavourable) Expressed in all Expressed in all spleen: 23.2 ZNF397 MGC13250, ZNF47, ZSCAN15 ENSG00000186812 Zinc finger protein 397 18 35241030-35267133 Predicted intracellular proteins, Transcription factors Evidence at protein level HPA026087 Uncertain Approved Nucleoli
Plasma membrane
Microtubules
Cytosol Pancreatic cancer:9.44e-4 (favourable) Expressed in all Expressed in all parathyroid gland: 32.8